About tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate
tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate (PubChem CID 129261700) has the molecular formula C31H39ClN8O2
and a molecular weight of 591.16 g/mol. Its IUPAC name is tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate |
| PubChem CID | 129261700 |
| Molecular Formula | C31H39ClN8O2 |
| Molecular Weight | 591.16 g/mol |
| Exact Mass | 590.29 |
| IUPAC Name | tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate |
| SMILES | CC(c1ccnc(Nc2nc3c(Cl)c(-c4cnn(CC5CCC5)c4)ccc3[nH]2)c1)N1CCN(C(=O)OC(C)(C)C)CC1 |
| InChI | InChI=1S/C31H39ClN8O2/c1-20(38-12-14-39(15-13-38)30(41)42-31(2,3)4)22-10-11-33-26(16-22)36-29-35-25-9-8-24(27(32)28(25)37-29)23-17-34-40(19-23)18-21-6-5-7-21/h8-11,16-17,19-21H,5-7,12-15,18H2,1-4H3,(H2,33,35,36,37) |
| InChIKey | DRIHAJSGEFGXAT-UHFFFAOYSA-N |
| XLogP | 6.63 |
| TPSA | 104.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 591.16 |
| LogP ≤ 5 | 6.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate?
The IUPAC name of tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate (CID 129261700) is tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate.
What is the SMILES notation for tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate?
The canonical SMILES for tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate is CC(c1ccnc(Nc2nc3c(Cl)c(-c4cnn(CC5CCC5)c4)ccc3[nH]2)c1)N1CCN(C(=O)OC(C)(C)C)CC1.
What is the InChIKey of tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate?
The InChIKey is DRIHAJSGEFGXAT-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H39ClN8O2/c1-20(38-12-14-39(15-13-38)30(41)42-31(2,3)4)22-10-11-33-26(16-22)36-29-35-25-9-8-24(27(32)28(25)37-29)23-17-34-40(19-23)18-21-6-5-7-21/h8-11,16-17,19-21H,5-7,12-15,18H2,1-4H3,(H2,33,35,36,37).
What are the key properties of tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate?
tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate has a molecular weight of 591.16 g/mol, XLogP of 6.63, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 4-[1-[2-[[4-chloro-5-[1-(cyclobutylmethyl)pyrazol-4-yl]-1H-benzimidazol-2-yl]amino]-4-pyridinyl]ethyl]piperazine-1-carboxylate is sourced from PubChem (CID 129261700), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).